...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >AN EVALUATION OF ACUTE AND SUBCHRONIC TOXICITIES OF A NIGERIAN POLYHERBAL ANTIDIABETIC REMEDY
【24h】

AN EVALUATION OF ACUTE AND SUBCHRONIC TOXICITIES OF A NIGERIAN POLYHERBAL ANTIDIABETIC REMEDY

机译:尼日利亚多药抗糖尿病药的急性和亚慢性毒性评估

获取原文
           

摘要

The acute and subchronic toxicities of Nigerian polyherbal antidiabetic remedy, prepared from Gongrenema latifolium and Allium cepa (1:1) leaves was investigated in Swiss albino mice and rats of both sexes. For acute toxicity study, 1000-5000mg/kg of the combined extract were administered orally to rats and observed for 24 hours for obvious toxic symptoms and mortality. The median lethal dose of the combined extract (LD50) was estimated. In subchronic study, 1000-4000mg/kg of the combined extracts were orally administered daily for 90 days. Weight changes and selected biochemical and hematological parameters were determined periodically. At the end of the experiment, the liver tissues were harvested for histopathological examination. The estimated LD50of the combined extracts was above 5000mg/kg. There was no sign of weakness, anorexia and no significant reduction in body weight. There were non- significant (p>0.05) effects on hemoglobin concentration and PCV. There were transient significant (p<0.05) increases in ALT and AST. Liver cells photomicrographs at the 91stday showed slight changes in histo-architecture of the hepatocytes at 4000mg/kg. These results suggest that combined aqueous extracts of Gongrenema latifolium and Allium cepa (1:1) is safe in the treatment of diabetes mellitus
机译:在瑞士的白化病小鼠和两性大鼠中研究了用弓形虫和葱属(1:1)叶片制得的尼日利亚多草药抗糖尿病药的急性和亚慢性毒性。为了进行急性毒性研究,将1000-5000mg / kg的混合提取物口服给予大鼠,并观察24小时的明显毒性症状和死亡率。估计了联合提取物的中位致死剂量(LD50)。在亚慢性研究中,每天口服1000-4000mg / kg合并提取物,共90天。定期确定体重变化以及所选的生化和血液学参数。实验结束时,收集肝组织用于组织病理学检查。合并提取物的LD50估计值高于5000mg / kg。没有任何虚弱,厌食和体重明显减轻的迹象。对血红蛋白浓度和PCV无显着影响(p> 0.05)。 ALT和AST短暂升高(p <0.05)。第91天的肝细胞显微照片显示,在4000mg / kg的条件下,肝细胞的组织结构略有变化。这些结果表明,弓形虫和葱属的水提取物(1:1)在糖尿病治疗中是安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号